Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
UC San Diego receives $1.3 million grant to understand the role of misfolded tau proteins in dementia

UC San Diego receives $1.3 million grant to understand the role of misfolded tau proteins in dementia

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Peter Adams and Bing Ren receive NIH grant to join multi-institution initiative studying the aging process

Peter Adams and Bing Ren receive NIH grant to join multi-institution initiative studying the aging process

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

Specific factors may affect physical and mental quality of life among people with multiple sclerosis

Specific factors may affect physical and mental quality of life among people with multiple sclerosis

Leisure activities may help lower the risk of dementia

Leisure activities may help lower the risk of dementia

Abnormal size or functioning in the heart's left atrium may increase dementia risk

Abnormal size or functioning in the heart's left atrium may increase dementia risk

Research reveals a gut-brain pathway that contributes to the development of Alzheimer’s disease

Research reveals a gut-brain pathway that contributes to the development of Alzheimer’s disease

UNH researchers receive  $2.8 million NIH grant to develop and test social assistive robots

UNH researchers receive $2.8 million NIH grant to develop and test social assistive robots

Alzheimer’s disease is associated with characteristic gut metabolomic signatures

Alzheimer’s disease is associated with characteristic gut metabolomic signatures

Researchers unravel a novel molecular target of eicosapentaenoic acid

Researchers unravel a novel molecular target of eicosapentaenoic acid

New insights into the understanding of how ApoE variants contribute to Tau pathology in Alzheimer’s disease

New insights into the understanding of how ApoE variants contribute to Tau pathology in Alzheimer’s disease

How do female sex hormones affect sleep, and memory?

How do female sex hormones affect sleep, and memory?

Novel fusion protein drug for Alzheimer’s disease circumvents the neurotoxic inflammatory side effects

Novel fusion protein drug for Alzheimer’s disease circumvents the neurotoxic inflammatory side effects

Study shows how microglia contribute to slowdown of neuron activity linked with Alzheimer’s

Study shows how microglia contribute to slowdown of neuron activity linked with Alzheimer’s

Fully reduced form of vitamin K found to efficiently inhibit ferroptotic cell death

Fully reduced form of vitamin K found to efficiently inhibit ferroptotic cell death

Common viruses may play a role in some cases of Alzheimer's disease

Common viruses may play a role in some cases of Alzheimer's disease

Women with a history of hypertensive disorders of pregnancy more likely to develop dementia

Women with a history of hypertensive disorders of pregnancy more likely to develop dementia

Researchers assess Alzheimer's disease risk and anti-diabetic drugs

Researchers assess Alzheimer's disease risk and anti-diabetic drugs

Novel age predictor helps investigate heterogeneity in brain aging

Novel age predictor helps investigate heterogeneity in brain aging

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.